RE:RE:RE:RE:RE:Cantor report effectStill no news. All we have is indirect signs that something positive is going on, like the Cantor report or the renewed job offer for a global regulatory manager in oncology. Again, why hiring somebody to fill this position if your oncology trial is not minimally positive at this point? How would you convince somebody to leave a good job somewhere else to accept the job with Thera, only to end up without a job in six months because the oncology trial is a total failure? In my view, you hire somebody for that job only if you see something minimally positive in the open label trial.